Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Castillo-Tong DC"'
Autor:
Glajzer J; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany. jacek.glajzer@uk-erlangen.de.; Tumorbank Ovarian Cancer Network, Berlin, Germany. jacek.glajzer@uk-erlangen.de.; Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Erlangen, Glückstraße 11, Erlangen, Germany. jacek.glajzer@uk-erlangen.de., Castillo-Tong DC; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria., Richter R; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany., Vergote I; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Division of Gynecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Herestraat 49, Leuven, Belgium., Kulbe H; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Vanderstichele A; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Division of Gynecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Herestraat 49, Leuven, Belgium., Ruscito I; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Via di Grottarossa 1035, Rome, Italy., Trillsch F; Department of Obstetrics and Gynecology, University Hospital LMU Munich, Munich, Germany., Mustea A; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany., Kreuzinger C; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria.; Institute of Science and Technology Austria, Am Campus 1, Klosterneuburg, Austria., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Cancer,, Western General Hospital, Crewe Road South, Edinburgh, UK., Gabra H; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Taube ET; Institute of Pathology, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany., Dorigo O; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, CA, USA., Horst D; Institute of Pathology, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany., Keunecke C; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Baum J; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Angelotti T; Department of Anesthesiology, Perioperative and Pain Medicine, 300 Pasteur Drive H3580, Stanford, CA, USA., Sehouli J; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Braicu EI; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1, Berlin, Germany. elena.braicu@charite.de.; Tumorbank Ovarian Cancer Network, Berlin, Germany. elena.braicu@charite.de.; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, CA, USA. elena.braicu@charite.de.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Jan; Vol. 30 (1), pp. 35-45. Date of Electronic Publication: 2022 Sep 09.
Autor:
Westergaard MCW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Milne K; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Pedersen M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Hasselager T; Department of Pathology, Copenhagen University Hospital, 2730 Herlev, Denmark., Olsen LR; Department of Health Technology, Technical University of Denmark, 2800 Kgs Lyngby, Denmark.; Genomic Medicine, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Anglesio MS; Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC V5Z 1L3, Canada., Borch TH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Kennedy M; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Briggs G; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Ledoux S; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Decken IV; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V5Z 1L3, Canada., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Dec 18; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 18.
Autor:
Watrowski R; Department of Gynecology and Obstetrics, St. Josefskrankenhaus, Teaching Hospital of the University of Freiburg, Freiburg, Germany., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Obermayr E; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center - Gynecologic Cancer Unit, Medical University of Vienna, Vienna, Austria., Zeillinger R; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center - Gynecologic Cancer Unit, Medical University of Vienna, Vienna, Austria Robert.Zeillinger@meduniwien.ac.at.
Publikováno v:
Anticancer research [Anticancer Res] 2020 May; Vol. 40 (5), pp. 2487-2495.
Autor:
Poschner S; Division of Clinical Pharmacy and Diagnostics, Department of Pharmaceutical Chemistry, University of Vienna, 1090 Vienna, Austria., Wackerlig J; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, University of Vienna, 1090 Vienna, Austria., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Wolf A; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Decken IV; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria., Rižner TL; Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Pavlič R; Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Meshcheryakova A; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria., Mechtcheriakova D; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria., Fritzer-Szekeres M; Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, 1090 Vienna, Austria., Thalhammer T; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria., Jäger W; Division of Clinical Pharmacy and Diagnostics, Department of Pharmaceutical Chemistry, University of Vienna, 1090 Vienna, Austria.; Vienna Metabolomics Center (VIME), University of Vienna, 1090 Vienna, Austria.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jan 23; Vol. 12 (2). Date of Electronic Publication: 2020 Jan 23.
Autor:
Sonego M; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Pellarin I; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Costa A; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Vinciguerra GLR; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy.; Faculty of Medicine and Psychology, Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza,' Santo Andrea Hospital, 00189 Rome, Italy., Coan M; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Kraut A; University of Grenoble Alpes, CEA, INSERM, BIG-BGE, F-38000 Grenoble, France., D'Andrea S; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Dall'Acqua A; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Wien, 1090 Vienna, Austria., Califano D; Genomica Funzionale, Fondazione G. Pascale, IRCCS, National Cancer Institute, 80100 Naples, Italy., Losito S; Anatomia Patologica, Fondazione G. Pascale, IRCCS, National Cancer Institute, 80100 Naples, Italy., Spizzo R; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Couté Y; University of Grenoble Alpes, CEA, INSERM, BIG-BGE, F-38000 Grenoble, France., Vecchione A; Faculty of Medicine and Psychology, Department of Clinical and Molecular Medicine, University of Rome 'La Sapienza,' Santo Andrea Hospital, 00189 Rome, Italy., Belletti B; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Schiappacassi M; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy., Baldassarre G; Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081 Aviano, Italy.
Publikováno v:
Science advances [Sci Adv] 2019 May 08; Vol. 5 (5), pp. eaav3235. Date of Electronic Publication: 2019 May 08 (Print Publication: 2019).
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.
Autor:
Stanske M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: mandy.stanske@charite.de., Wienert S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany; VM Scope GmbH, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: stephanwienert@gmx.de., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address: dan.cacsire-castillo@meduniwien.ac.at., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address: caroline.kreuzinger@meduniwien.ac.at., Vergote I; Department of Gynecology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Lambrechts S; Department of Gynecology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: sandrijne.lambrechts@gmail.com., Gabra H; Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, South Kensington Campus, London SW7 2AZ, UK. Electronic address: h.gabra@imperial.ac.uk., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK. Electronic address: charlie.gourley@ed.ac.uk., Ganapathi RN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas Health Care System, 1021 Morehead Medical Drive, Charlotte, NC 28204-2839, USA. Electronic address: ram.ganapathi@carolinashealthcare.org., Kolaschinski I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: ivonne.kolaschinski@charite.de., Budczies J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: jan.budczies@charite.de., Sehouli J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: jalid.sehouli@charite.de., Ruscito I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany; UP Cell Therapy and Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy. Electronic address: ilary.ruscito@uniroma1.it., Denkert C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: carsten.denkert@charite.de., Kulbe H; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: hagen.kulbe@charite.de., Schmitt W; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: wolfgang.schmitt@charite.de., Jöhrens K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: korinna.joehrens@charite.de., Braicu I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: ioana@braicu.de., Darb-Esfahani S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: silvia.darb-esfahani@charite.de.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2018 Mar; Vol. 20 (3), pp. 280-288. Date of Electronic Publication: 2018 Feb 22.
Autor:
Obermayr E; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Bednarz-Knoll N; Institute of Tumor Biology, University Medical Center Eppendorf, Hamburg, Germany., Orsetti B; INSERM U1194, IRCM, Université de Montpellier, Montpellier, France.; Institut du Cancer de Montpellier, Montpellier, France., Weier HU; Department of Cancer and DNA Damage Responses, Life Sciences Division, University of California, Lawrence Berkeley National Laboratory, Berkeley, CA, USA., Lambrechts S; Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Castillo-Tong DC; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Reinthaller A; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Braicu EI; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité- Universitätsmedizin Berlin, Berlin, Germany., Mahner S; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité- Universitätsmedizin Berlin, Berlin, Germany., Vergote I; Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven Cancer Institute, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Theillet C; INSERM U1194, IRCM, Université de Montpellier, Montpellier, France.; Institut du Cancer de Montpellier, Montpellier, France., Zeillinger R; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria., Brandt B; Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2017 Nov 16; Vol. 8 (63), pp. 106415-106428. Date of Electronic Publication: 2017 Nov 16 (Print Publication: 2017).
Autor:
Kenn M; Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, A-1090 Vienna, Austria., Schlangen K; Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, A-1090 Vienna, Austria., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria., Singer CF; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria., Cibena M; Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, A-1090 Vienna, Austria., Koelbl H; Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, A-1090 Vienna, Austria., Schreiner W; Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, A-1090 Vienna, Austria.
Publikováno v:
Oncotarget [Oncotarget] 2017 Aug 24; Vol. 8 (44), pp. 77341-77359. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).
Autor:
Mungenast F; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090 Vienna, Austria., Aust S; Department of Gynaecology and Gynaecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria., Vergote I; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Catholic University of Leuven, University Hospital, B-3000 Leuven, Belgium., Vanderstichele A; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Catholic University of Leuven, University Hospital, B-3000 Leuven, Belgium., Sehouli J; Department of Gynaecology, European Competence Center for Ovarian Cancer, Virchow Clinic Campus, Medical University of Berlin, D-13353 Berlin, Germany., Braicu E; Department of Gynaecology, European Competence Center for Ovarian Cancer, Virchow Clinic Campus, Medical University of Berlin, D-13353 Berlin, Germany., Mahner S; Department of Gynaecology and Obstetrics, University of Munich, D-80539 Munich, Germany., Castillo-Tong DC; Translational Gynaecology Group, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria., Zeillinger R; Molecular Oncology Group, Department of Obstetrics and Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria., Thalhammer T; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090 Vienna, Austria.
Publikováno v:
Oncology letters [Oncol Lett] 2017 Jun; Vol. 13 (6), pp. 4047-4054. Date of Electronic Publication: 2017 Apr 03.
Autor:
Flanagan JM; Department of Surgery and Cancer, Imperial College London, London, UK., Wilson A; Department of Surgery and Cancer, Imperial College London, London, UK., Koo C; Department of Surgery and Cancer, Imperial College London, London, UK., Masrour N; Department of Surgery and Cancer, Imperial College London, London, UK., Gallon J; Department of Surgery and Cancer, Imperial College London, London, UK., Loomis E; Department of Surgery and Cancer, Imperial College London, London, UK., Flower K; Department of Surgery and Cancer, Imperial College London, London, UK., Wilhelm-Benartzi C; Department of Surgery and Cancer, Imperial College London, London, UK., Hergovich A; UCL Cancer Institute, UCL, London, UK., Cunnea P; Department of Surgery and Cancer, Imperial College London, London, UK., Gabra H; Department of Surgery and Cancer, Imperial College London, London, UK., Braicu EI; Department of Gynecology, European Competence Center for Ovarian Cancer; Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network (TOC), Berlin, Germany., Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer; Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network (TOC), Berlin, Germany., Darb-Esfahani S; Tumorbank Ovarian Cancer Network (TOC), Berlin, Germany.; Institute of Pathology, Charitéplatz, Berlin, Germany., Vanderstichele A; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Vergote I; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Wisman GBA; Department of Gynecologic Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Berns EM; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands., Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK., Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, UK., Brown R; Department of Surgery and Cancer, Imperial College London, London, UK. E-mail:b.brown@imperial.ac.uk.; Section of Molecular Pathology, Institute for Cancer Research, Sutton, UK.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 May 01; Vol. 23 (9), pp. 2213-2222. Date of Electronic Publication: 2016 Sep 23.